Ben Hadda, T. Et Al. 2021. Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies. MEDICINAL CHEMISTRY , vol.17, no.8 , 834-843.

Ben Hadda, T., ŞENOL DENİZ, F. S., ERDOĞAN ORHAN, İ., Zgou, H., Rauf, A., Mabkhot, Y. N., ... Bennani, B.(2021). Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies. MEDICINAL CHEMISTRY , vol.17, no.8, 834-843.

Ben Hadda, Taibi Et Al. "Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies," MEDICINAL CHEMISTRY , vol.17, no.8, 834-843, 2021

Ben Hadda, Taibi B. Et Al. "Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies." MEDICINAL CHEMISTRY , vol.17, no.8, pp.834-843, 2021

Ben Hadda, T. Et Al. (2021) . "Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies." MEDICINAL CHEMISTRY , vol.17, no.8, pp.834-843.

@article{article, author={Taibi Ben Hadda Et Al. }, title={Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies}, journal={MEDICINAL CHEMISTRY}, year=2021, pages={834-843} }